Borealis Raises $150M in Series A Funding for RNA Medicines - Funding Raised

Borealis Raises $150M in Series A Funding for RNA Medicines

Vancouver-based Borealis secured $150M in Series A funding, led by Versant Ventures and Novartis AG. The funds will enhance their RNA medicine development. Novartis also gains an option to acquire two future programs, potentially earning Borealis up to $750M through clinical and regulatory milestones.

Latest News

Read More

BlissClub

BlissClub Funding D2C Athleisure Brand ने जुटाए ₹160 करोड़,

BlissClub ने Singularity AMC के नेतृत्व में ₹160 करोड़ Series B funding जुटाई। जानिए founders, revenue, loss, business

By Vaishali Sharma

PayGlocal

PayGlocal Funding $120 Million Valuation पर जुटाएगा ₹36 करोड़,

PayGlocal $120 million valuation पर ₹36.38 करोड़ जुटाने जा रहा है। जानिए funding, founders, revenue, RBI licence, business

By Vaishali Sharma

Benne

Benne Funding Bengaluru-Style Dosa Chain ने जुटाए ₹35 करोड़,

Benne ने ₹35 करोड़ की Pre-Series A funding जुटाई है। जानिए Claypond Capital investment, ₹364 करोड़ valuation, founders,

By Vaishali Sharma